These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9808435)

  • 1. Differential expression of SHP2, a protein-tyrosine phosphatase with SRC homology-2 domains, in various types of renal tumour.
    Kuroda N; Hayashi Y; Matozaki T; Hanioka K; Gotoh A; Wang W; Uchida H; Hashimoto K; Iwai Y; Kawasaki K; Imai Y; Kasuga M; Itoh H
    Virchows Arch; 1998 Oct; 433(4):331-9. PubMed ID: 9808435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of vitamin D3 receptor in kidney tumors.
    Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T
    Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paxillin: application of immunohistochemistry to the diagnosis of chromophobe renal cell carcinoma and oncocytoma.
    Kuroda N; Guo L; Toi M; Naruse K; Miyazaki E; Hayashi Y; Yoshikawa C; Ashida S; Shuin T; Enzan H
    Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):315-8. PubMed ID: 11759057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominant expression of the src homology 2-containing tyrosine phosphatase protein SHP2 in vascular smooth muscle cells.
    Adachi M; Iwaki H; Shindoh M; Akao Y; Hachiya T; Ikeda M; Hinoda Y; Imai K
    Virchows Arch; 1997 Apr; 430(4):321-5. PubMed ID: 9134043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SH2 tyrosine phosphatase shp2 is required for mammalian limb development.
    Saxton TM; Ciruna BG; Holmyard D; Kulkarni S; Harpal K; Rossant J; Pawson T
    Nat Genet; 2000 Apr; 24(4):420-3. PubMed ID: 10742110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillary renal cell carcinoma within a renal oncocytoma: case report of an incidental finding of a tumour within a tumour.
    Rowsell C; Fleshner N; Marrano P; Squire J; Evans A
    J Clin Pathol; 2007 Apr; 60(4):426-8. PubMed ID: 17405978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.
    Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL
    Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma.
    Wang KL; Weinrach DM; Luan C; Han M; Lin F; Teh BT; Yang XJ
    Hum Pathol; 2007 Feb; 38(2):239-46. PubMed ID: 17056094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoexpression of napsin A in renal neoplasms.
    Zhu B; Rohan SM; Lin X
    Diagn Pathol; 2015 Mar; 10():4. PubMed ID: 25889632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: biologic implications and differential diagnostic potential.
    Tickoo SK; Amin MB; Linden MD; Zarbo RJ
    Mod Pathol; 1998 Nov; 11(11):1115-21. PubMed ID: 9831210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of insulin-stimulated glycogen synthesis by Src Homology Phosphatase 2.
    Ouwens DM; van der Zon GC; Maassen JA
    Mol Cell Endocrinol; 2001 Apr; 175(1-2):131-40. PubMed ID: 11325523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
    Pan CC; Chen PC; Ho DM
    Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma.
    Mazal PR; Exner M; Haitel A; Krieger S; Thomson RB; Aronson PS; Susani M
    Hum Pathol; 2005 Jan; 36(1):22-8. PubMed ID: 15712178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex.
    Bode JG; Schweigart J; Kehrmann J; Ehlting C; Schaper F; Heinrich PC; Häussinger D
    J Immunol; 2003 Jul; 171(1):257-66. PubMed ID: 12817006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative regulation of gp130 signalling mediated through tyrosine-757 is not dependent on the recruitment of SHP2.
    Fairlie WD; De Souza D; Nicola NA; Baca M
    Biochem J; 2003 Jun; 372(Pt 2):495-502. PubMed ID: 12593670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
    Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
    J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.